AbbVie (ABBV) Change in Taxes (2019 - 2026)

AbbVie (ABBV) has reported Change in Taxes for 8 consecutive years, with -$2.2 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Taxes fell 61.67% year-over-year to -$2.2 billion in Q2 2026; TTM through Jun 2026 was -$2.1 billion, a 24.74% increase from a year earlier, with the FY2025 full-year figure at -$762.0 million, up 76.25% from the prior year.
• Change in Taxes was -$2.2 billion for Q2 2026 at AbbVie, down from -$81.0 million in the prior quarter.
• Over five years, Change in Taxes peaked at $646.0 million in Q4 2025 and troughed at -$2.2 billion in Q2 2026.
• A 5-year average of -$345.6 million and a median of $42.0 million in 2023 frame the typical range for Change in Taxes.
• Across the five-year window, Change in Taxes surged 545.45% in 2022 and sank 905.88% in 2025, its largest moves.
• Over 5 years, Change in Taxes stood at $358.0 million in 2022, then gained by 14.8% to $411.0 million in 2023, then sank by 538.69% to -$1.8 billion in 2024, then surged by 135.83% to $646.0 million in 2025, then sank by 444.12% to -$2.2 billion in 2026.
• The last three Change in Taxes figures came in at -$2.2 billion (Q2 2026), -$81.0 million (Q1 2026), and $646.0 million (Q4 2025), per Business Quant data.